In Wilm’s tumor the following leads to emergence of resistance to chemotherapy –
**Core Concept**
Wilm's tumor, a type of kidney cancer, is a pediatric malignancy that requires aggressive chemotherapy for treatment. The emergence of resistance to chemotherapy is a significant challenge in the management of this disease.
**Why the Correct Answer is Right**
The development of resistance to chemotherapy in Wilm's tumor is attributed to the presence of the multidrug resistance protein 1 (MDR1), also known as P-glycoprotein. This protein acts as an efflux pump, actively removing chemotherapeutic agents from the cancer cells, thereby reducing their effectiveness. The overexpression of MDR1 is a common mechanism of resistance to chemotherapy in Wilm's tumor.
**Why Each Wrong Option is Incorrect**
**Option A:** None of the other options directly relate to the mechanism of resistance to chemotherapy in Wilm's tumor.
**Option B:** Genetic mutations in the tumor suppressor gene WT1 are associated with the development of Wilm's tumor, but they do not directly contribute to resistance to chemotherapy.
**Option C:** Angiogenesis, the formation of new blood vessels, is an important aspect of tumor growth and metastasis, but it is not directly related to resistance to chemotherapy.
**Clinical Pearl / High-Yield Fact**
It is essential for clinicians to be aware of the mechanisms of resistance to chemotherapy in Wilm's tumor, as this knowledge can guide the selection of alternative chemotherapeutic agents and strategies to overcome resistance.
**Correct Answer:** C. Angiogenesis is the process by which tumors establish their blood supply, but it is not directly related to resistance to chemotherapy in Wilm's tumor.